Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Steinemann

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Science Translational Medicine|March 14, 2014
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicityChristian Jörg Braun, Kaan Boztug, Anna Paruzynski, et al.
Blood|February 14, 2014
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesisJulia Skokowa, Doris Steinemann, Jenny E Katsman-Kuipers, et al.
The Journal of Clinical Investigation|February 26, 2013
Parthenogenetic stem cells for tissue-engineered heart repairMichael Didié, Peter Christalla, Michael Rubart, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2018
IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic LeukemiaMartin Stanulla, Elif Dagdan, Marketa Zaliova, et al.
Nature Communications|February 27, 2020
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variantsAna Rio-Machin, Tom Vulliamy, Nele Hug, et al.
Blood|September 27, 2023
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyDaria Frank, Pradeep Kumar Patnana, Jan Vorwerk, et al.
American Journal of Medical Genetics. Part A|February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyTim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
Human Molecular Genetics|March 25, 2016
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithmsMiguel de la Hoya, Omar Soukarieh, Irene López-Perolio, et al.
Breast Cancer Research : BCR|February 10, 2016
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Science Translational Medicine|March 14, 2014
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicityChristian Jörg Braun, Kaan Boztug, Anna Paruzynski, et al.
Blood|February 14, 2014
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesisJulia Skokowa, Doris Steinemann, Jenny E Katsman-Kuipers, et al.
The Journal of Clinical Investigation|February 26, 2013
Parthenogenetic stem cells for tissue-engineered heart repairMichael Didié, Peter Christalla, Michael Rubart, et al.
Haematologica|October 12, 2019
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocolsGunnar Cario, Veronica Leoni, Valentino Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2018
IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic LeukemiaMartin Stanulla, Elif Dagdan, Marketa Zaliova, et al.
Nature Communications|February 27, 2020
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variantsAna Rio-Machin, Tom Vulliamy, Nele Hug, et al.
Blood|September 27, 2023
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyDaria Frank, Pradeep Kumar Patnana, Jan Vorwerk, et al.
American Journal of Medical Genetics. Part A|February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyTim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
Human Molecular Genetics|March 25, 2016
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithmsMiguel de la Hoya, Omar Soukarieh, Irene López-Perolio, et al.
Breast Cancer Research : BCR|February 10, 2016
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, et al.
Pageof 14